Three different models of continuous manufacturing are described in the draft guideline. The guideline incorporates the ICH Q7 definition of a batch to continuous manufacturing.
The acquisition includes Teneobio's proprietary bispecific and multispecific antibody technologies, which will enable significant acceleration and efficiency in the discovery and development of new molecules.
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential...